De-escalation: Clinical Trials

5 trials of De-escalation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 1 completed, 1 terminated. 3 Not applicable, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable3Recruiting 2, Terminated 1
Phase 31Recruiting 1
Phase 41Completed 1

Follow De-escalation: new trials by email Literature Review of De-escalation trials Research Report on De-escalation

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Adjuvant Ribociclib
Chemotherapy followed by endocrine therapy and ribociclib treatment, De-escalation - Breast Cancer
Phase 3RecruitingUNICANCER39022025-12-182026-05-26
De-escalation of Radiation Dose in HPV-associated OPC Utilising FMISO PET (DE-RADIATE)
De-escalation, Standard of care - HPV Positive Oropharyngeal Squamous Cell Carcinoma
Not applicableRecruitingRoyal North Shore Hospital252025-04-012025-07-30
The T-REX Trial: Tailored Regional External Beam Radiotherapy in Clinically Node-negative Breast Cancer Patients With 1-2 Sentinel Node Macrometastases.
De-escalation - Breast Cancer
Not applicableRecruitingRegion Skane13502023-03-172026-05-11
Ticagrelor-based De-escalation of Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting
De-escalated Dual Antiplatelet Therapy, Dual Antiplatelet Therapy - Coronary Artery Disease, Coronary Artery Bypass Grafting
Phase 4CompletedChina National Center for Cardiovascular Diseases23002023-02-142025-08-27
A B-D-Glucan Driven Antifungal Stewardship Approach for Invasive Candidiasis
De-escalation - Invasive Candidiases, Abdominal Infection
Not applicableTerminatedUniversity of Bologna342017-03-012024-08-28

Conditions studied

Breast Neoplasms (2)  ·  Angina Pectoris (1)  ·  Candidiasis, Invasive (1)  ·  Coronary Artery Disease (1)  ·  Hemorrhage (1)  ·  Hypoxia (1)  ·  Intraabdominal Infections (1)  ·  Myocardial Infarction (1)  ·  Myocardial Ischemia (1)

Sponsors

China National Center for Cardiovascular Diseases (1)  ·  Region Skane (1)  ·  Royal North Shore Hospital (1)  ·  UNICANCER (1)  ·  University of Bologna (1)

Countries

Italy (2)  ·  Australia (1)  ·  China (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Netherlands (1)  ·  Norway (1)  ·  Spain (1)  ·  Sweden (1)

Top investigators

Anna Lawless (1)  ·  Kai Chen (1)  ·  Qing Chu, PhD (1)  ·  Sara Alkner, Associate professor (1)  ·  Sarah Bergamin (1)  ·  Shengshou Hu, MD (1)  ·  Xin Yuan, PhD (1)

Results publications

PMID 37385747, PMID 37751948, PMID 42120081

NIH funding

2025 (1)